LONDON, Nov. 20, 2014 /PRNewswire/ --
The global market for intravenous therapy and vein access was $19.3 billion in 2013. The market reached $20.3 billion in 2014 and is expected to reach about $27.2 billion in 2019, registering a compound annual growth (CAGR) of 6.0% over the next five years.
This report provides:
An overview of the global markets and technologies for intravenous (IV) therapy and vein access.
Analyses of market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
Detailed information on the main categories for IV therapy including ambulatory infusion pumps, central venous access devices, Diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps.
Identification of current products on the market.
Assessments of the competitive landscape and competitor market shares.
SCOPE OF THE STUDY
The scope of this study encompasses all intravenous (IV) therapy drugs and devices, including intravenous solutions, administration sets and other accessories, infusion pumps and venous access devices used for therapeutic purposes. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. The report addresses the latest trends and developments in technology. The report also discusses the growing demand for IV therapy drugs and devices in emerging markets, which include countries such as India, China, Japan and Korea.
Download the full report: https://www.reportbuyer.com/product/297995/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers